According to current policy, chemicals are evaluated for possible cancer risk to humans at low dose by testing in bioassays, where high doses of the chemical are given to rodents. Thus, risk is extrapolated from high dose in rodents to low dose in humans. The accuracy of these extrapolations is generally unverifiable, since data on humans are limited. However, it is feasible to examine the accuracy of extrapolations from mice to rats. If mice and rats are similar with respect to carcinogenesis, this provides some evidence in favor of inter-species extrapolations; conversely, if mice and rats are different, this casts doubt on the validity of extrapolations from mice to humans.
Introduction
According to current regulatory policy, chemicals are tested for carcinogenicity in rodent bioassays, where rats and mice are exposed to near-toxic doses of the agent on test. High doses are needed in order to demonstrate a statistically significant response with a limited number of animals. But there is an upper bound: if the dose level is set too high, animals will not live long enough to develop cancer. Thus, chemicals are administered at the "Maximum Tolerated Dose," or MTD. (Details on the MTD and bioassay design are in Section 2.) Typically, the MTD is orders of magnitude higher than the environmental exposures of concern for the general population. To use bioassay results for risk assessment, then, two extrapolations are needed: (1) the species extrapolation from rats or mice to humans, and (2) the extrapolation from high dose to low dose. The first extrapolation is qualitative; the second is quantitative and depends on a dose-response model like the "one-hit model" (Section 2).
The focus of the present paper is the validity of the qualitative extrapolation. It is often said that most known human carcinogens are also animal carcinogens. This familiar argument, however, faces certain empirical difficulties (Freedman and Zeisel, 1988) . Moreover, the argument bypasses the main question of policy interest-are most animal carcinogens also human carcinogens?
Indirect evidence can be used to validate the species extrapolation;
for example, the accuracy of extrapolations from mice to rats can be examined. If mice and rats are similar with respect to carcinogenesis, this provides some evidence in favor of inter-species extrapolation; conversely, if mice and rats are different, this casts doubt on extrapolations from rodents to humans. Data from National Cancer Institute/National Toxicology Program (NCI/NTP) are convenient for this purpose. NCI/NTP bioassays are run on a standard protocol and (with few exceptions) each chemical is tested both in rats and in mice.
Using the Carcinogenic Potency Data Base, we identified 297 chemicals tested by NCI/NTP in female mice and female rats (Gold et al., 1984 (Gold et al., , 1990 . We classified each chemical as positive (+) or negative (−) in the female mouse and in the female rat, based on significance at the .005 level, one sided. This rule produces a classification in good agreement with "authors' opinion" (Haseman, 1983b; Gold et al., 1989) .
Being mechanical, the rule is subject to simulation study; using females avoids complications created by sex-specific responses. (Results for males are quite similar, although concordance is a bit lower.)
One measure of inter-species agreement is concordance, the percentage of chemicals that are classified the same way in both species. Results for NCI/NTP bioassays are shown in Table 1 . There were 53 + 48 + 22 + 174 = 297 chemicals; of them, 53 + 174 = 227 were classified the same way in mice and in rats; the concordance is 227/297 = 76%. (Concordance has been computed by a number of authors, and 75% is a typical figure; see Gold et al. 1989 or Krewski et al. 1993 Mice and rats are, after all, very similar species being tested under virtually identical experimental conditions; it might therefore be argued that a concordance of 76% brings into question the validity of the extrapolation from rodents to humans. A possible counter-argument: the concordance observed in the NCI/NTP data is just an estimate based on limited data.
Since each bioassay only involves a relatively small number of mice and rats, statistical power may be low. Thus, observed concordance could be lower than true concordance, just due to measurement error in the bioassays. Indeed, an observed concordance of 76% could imply a true concordance near 100%.
This paper follows Piegorsch et al. (1992) in exploring the question via computer simulations of the bioassay process. We expand the framework to include the case where true concordance is less than 100%, and make the simulations more realistic in other ways too. The data generated in our simulations look rather like the real NCI/NTP data with respect to summary statistics on potency and toxicity. We show that observed concordance can be 76%-the value in Table 1-if true concordance The balance of this paper is organized as follows. Section 2 gives some detail on bioassays and the one-hit dose-response model. Section 3 describes previous simulation studies, identifies the crucial assumptions, and compares the results to real data. Section 4 describes our simulations. There is a discussion and literature review in section 5, while technical details are given in section 6. This paper is based on Lin et al. (1995) , which may be consulted for additional results and further explanations, and a review of work on the quantitative extrapolation.
Background
Standard NCI/NTP bioassay protocols call for testing chemicals in two species (mice and rats) and in both sexes. For a given sex and species, there are three dose groups (high dose, low dose, control), each with 50 animals.
The high dose group is given the Maximum Tolerated Dose (MTD), estimated using data from a subchronic experiment; the MTD is the dose that is expected to produce a 10% decrement in weight gain but does not cause death or overt toxicity (Sontag et al., 1976) . The low dose group receives half the MTD. The control group receives none of the chemical.
The probability that an animal develops cancer is often assumed to follow the one-hit model:
(1)
In equation (1) Crouch et al. (1987) and Shlyakhter et al. (1992) .
The Cochran-Armitage Trend Test (Snedecor and Cochran, 1967; Gart et al., 1986) can be used to determine if bioassay results are "statistically significant," meaning they show a significant (positive) trend with dose. On genetic heterogeneity, see Gaylor et al. (1993) or Peto et al. (1985, p.46) .
Previous Simulations
This section will summarize the simulation model used by Piegorsch et al. (1992) ; details are in section 6 below; also see Lin et al. (1995) . The model has three parameters: p 0 , the background rate of cancer; ρ, which controls the inter-species correlation; and α, a one-sided significance level.
Based on these parameters, 2000 sets of 100 "chemicals" are generated Each "chemical" is subjected to a simulated NCI/NTP bioassay involving two species (mice and rats), three dose groups (control, low dose, high dose), and 50 animals per dose group. The probability of cancer follows the standard one-hit model, equation (1) Piegorsch et al. report that p 0 = .10, ρ = .9, and α = .025 give simulated concordances that are similar to NCI/NTP data (Table 1) . However, other aspects of their simulation are quite unrealistic, as shown in Figure 1 for mice (the plot for rats would be similar). The horizontal axis shows log 10 potency; the vertical axis shows log 10 (1/MTD). Each of the 143 dots corresponds to an NCI/NTP bioassay that had significant results in mice at the .025 level. The dashed line is the graph of equation (4) below, which is the theoretical relationship between toxicity and potency built into the simulation model. The real NCI/NTP data do not follow the theoretical line.
We computed the box in Figure 1 by generating 100,000 statistically significant (α = .025) chemicals according to the procedure described above, with p 0 = .10 and ρ = .9. The horizontal edges of the box show the mean log potency, plus or minus three standard deviations. The vertical edges of the box show the mean log 10 (1/MTD), plus or minus three standard deviations.
Among the 100,000 simulated chemicals, 98.1% had values inside the box.
By contrast, among the 143 NCI/NTP chemicals, only 8 had values inside the box. The box covers only a very small part of the real data: you may need to look closely at the figure to see the box.
There is another unrealistic assumption that drives the results in Piegorsch et al.'s simulations: all chemicals are assumed carcinogenic both for mice and for rats-so true concordance is 100%. It is therefore not surprising that concordance is under-estimated. The observed concordance has nowhere to go but down. the observed classification may differ from the true classification, due to statistical error. We define the population so that some chemicals are in truth non-carcinogenic. The true (unobservable) potencies and MTDs are chosen so the distribution of estimated potencies and MTDs looks rather like the NCI/NTP data. In particular, with our simulations, observed concordance will be about 76%. However, the true concordance-in the population of all possible chemicals-ranges from 20% to 100%. These results suggest that bias in observed concordance is not determined by the data. In this model, carcinogenicity is independent between the two species:
the mouse carcinogen, just like the mouse non-carcinogen, has a 50% chance to be a rat carcinogen. Information about carcinogenicity in one species
gives no information about carcinogenicity in the other species. Yet observed concordance is 76%, just as in the NCI/NTP data. Figure 2 compares the simulated bioassay data in mice for this model to the real NCI/NTP data; the match is reasonable-but hardly perfect. Similar conclusions would hold for rats, for mice vs. rats, etc.
For model B (line 2 of Table 2 ), true concordance is 18% and there is an inverse relationship between the two species. In truth, among the mouse carcinogens, only 18/(18 + 53) = 25% are rat carcinogens; however, among the mouse non-carcinogens, 100% are rat carcinogens. Thus, carcinogenicity in one species points in truth to non-carcinogenicity in the other. Yet observed concordance is 76%. Summary statistics on potency and toxicity also match the real data. 
What is the source of the bias?
Each chemical belongs to one of four categories, depending on "true" mouse-and rat-carcinogenicity (i.e., "++", "+−", and so forth); also, each chemical belongs to one of four categories, depending on "observed" carcinogenicity. This gives rise to a 4 × 4 matrix. Results for our first model are presented in Table 3 . The column totals give the average "true" number of each type of chemical. The row totals give the average "observed" number of each type of chemical, the basis for the observed concordance in the 6th column of Table 2 . Table 3 give percent-ages, with 297 as the base. (Detail may not add to total, due to independent rounding; the last row in Table 3 differs from the first row in Table 2 , due to sampling error; from the last column in Table 3 , the observed concordance in model A is 17.8% + 58.5% = 76.3%; this is rounded to 76% in Table 2 .)
On the average, 59.3 out of the 297 chemicals were true "++". Most of these (52.5) were observed as "++" in the simulated bioassays, but an average of 3.9+2.7 were misclassified as discordant ("+−" or "−+"). Also, 89.0 chemicals were true "−−"; of these, an average of .4 + .4 were misclassified as discordant. The average total number of false discordances can thus be computed as 3.9 + 2.7 + .4 + .4 = 7.4. On the other hand, the average total number of false concordances is .2 + .1 + 15.4 + 70.0 = 85.7. The number of false concordances is much larger than the number of false discordances: in particular, the observed "−−" cell is inflated, due to lack of power in the bioassay. This is what makes the observed concordance much larger than the true concordance.
Discussion
Piegorsch et al. (1992) These results have been cited as showing that observed concordance is biased downward, so that 80% is an upper bound on observable concordance; see, for instance, (Huff et al., 1991) and (Haseman and Seilkop, 1992) . However, the results are based on assumptions about the true (unobservable) parameters governing chemical carcinogenicity. These assumptions are somewhat unrealistic (Figure 1 ). Furthermore, Piegorsch et al. have in effect assumed that all chemicals are carcinogenic in both species, so true concordance is 100%. On that basis, observed concordance has nowhere to go but down.
As Table 2 demonstrates, it is possible to have low true concordance but moderately high observed concordance. It is even possible to have a high true concordance and a higher observed concordance. In these models, observed concordance is biased high, on the average across all chemicals.
Of course, it is also possible to have a true concordance of 100% but only Like previous authors, we used a variant of the one-hit model. We made some allowance for specification error, because-if examined in detail-the one-hit model may be rejected. For reviews, see Food Safety Council (1980), Freedman and Zeisel (1988) ; also see Peto et al. (1984) , Cancer Research (1991) Vol. 51 No. 23 Part 2 pp.6407-6491, Meier et al. (1993) , Hoel and Portier (1994) .
Too, there are familiar difficulties in using the data to discriminate among models; for a recent discussion, see Kopp-Schneider and Portier (1991) . In some respects, the "multistage model" extends the one-hit model, taking into account duration as well as level of dose and time to tumor; even this more general model will not fit a number of data sets Navidi, 1989, 1990) . Also see Moolgavkar (1990 Moolgavkar ( , 1994 , who discusses alternative models. Because of uncertainties about dose-response models, sim-ulation studies are rather idealized versions of reality. Such studies cannot
give definitive evidence about concordance, but can indicate the complexities in estimating measures of inter-species agreement from bioassay data.
Worst-case analysis
In a bioassay, some 35 target organs are examined, and risk assessment is based on the most sensitive site. In other words, classification of carcinogenicity is based on the response at the most sensitive site, and extrapolations from rodent to human are based on the potency at this site.
However, rodent carcinogens often increase the tumor rate at some sites but decrease the rate at other sites-even in the same sex-species group in the same experiment. (A further complication: animals in the treatment groups tend to weigh less, and lower body weight is associated with a reduction in tumor incidence.) We think that both the positive and the negative trends should be considered when assessing carcinogenicity-a topic not addressed by our simulations. In effect, like previous authors, we studied concordance of worst-case analyses in mice and rats. For reviews, see Haseman (1983a) , Salsburg (1983), Freedman and Zeisel (1988) , Davies and Monro (1994) , Haseman and Johnson (1996) . Piegorsch et al. (1992) use a simulation study to examine potential bias in observed concordance. The study is keyed to data from the Carcinogenic Potency Data Base of Gold et al. (1984 . As previously noted, each "chemical" is subjected to a simulated NCI/ NTP bioassay involving two species (mice and rats), three dose groups (control, low dose, high dose), and 50 animals per dose group. The probability of cancer follows the standard one-hit model: equation (1) sided. This leads to a classification as "++", "+−", "−+", or "−−", where the first and second symbols denote the observed carcinogenicity in mice and rats, respectively. The test for trend is applied to tumor rates in the three dose groups; time-to-tumor is not considered.
Technical details
We turn now to our simulations. Each "chemical" is generated as a set For the parameters and their rationale, see Lin et al. (1995) .
In our simulations, the probability of cancer is assumed to follow the one-hit model (1) level, one-sided, as noted above; changing levels from .005 to .025 would not alter the concordances appreciably; however, the 2 × 2 table would no longer match the NCI/NTP data so well, unless other parameters were also changed.
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